Pharmaceuticals
Philips to buy medical device maker Volcano Corp for $1.2 bn
17 Dec 2014
Dutch diversified technology company Philips N V today struck a deal to buy US medical device maker Volcano Corp, for $1.2 billion including debt
Merck & Co to buy Cubist Pharmaceuticals for $8.4 bn
10 Dec 2014
Merck expects the acquisition to add more than $1 billion of revenue after closing in the first quarter, but will be neutral to non-GAAP earnings per share until 2016
Sun Pharma, Ranbaxy merger deal gets conditional CCI nod
09 Dec 2014
The CCI has asked the two companies to sell off seven brands with combined sales of less than Rs50 crore and market share of 60 to 80 per cent, which the regulator felt, would adversely affect competition
Merck & Co in talks to buy Cubist Pharmaceuticals for more than $7 bn
06 Dec 2014
Cubist Pharmaceuticals develops drugs for potentially life-threatening infections caused by dangerous bacteria categorised as serious and urgent public health threats
.webp)
